Cures Within Reach

• NCT07297290

  Collaborator, Phase 3, Recruiting, 220 people, 22 Dec 2025

• NCT05420350

  Collaborator, Phase 2, Status unknown, 34 people, 15 Jun 2022

• NCT04915846

  Collaborator, Phase 1/2, Terminated, 6 people, 7 Jun 2021

• NCT04721795

  Collaborator, Phase 2/3, Completed, 150 people, 25 Jan 2021

• NCT04551131

  Collaborator, Phase 1/2, Active, not recruiting, 10 people, 16 Sept 2020

• NCT02611921

  Collaborator, Phase 1, Completed, 21 people, 23 Nov 2015

• NCT01576783

  Collaborator, Phase 4, Completed, 377 people, 12 Apr 2012

• Mitochon Pharmaceuticals

Sources: mitochonpharma.com

• Canagliflozin Reprograms the Aging Hippocampus in Genetically Diverse UM-HET3 Mice and Attenuates Alzheimer's-Like Pathology

  P30ES036084, 5 Oct 2025

Sources: api.crossref.org